Maria Mazzitelli Selected Research

Maria Mazzitelli Research Topics

Disease

22	COVID-19 12/2023 - 01/2020
19	Infections 12/2023 - 07/2016
5	Pneumonia (Pneumonitis) 10/2023 - 01/2021
5	Sepsis (Septicemia) 10/2023 - 10/2019
4	Body Weight (Weight, Body) 07/2022 - 12/2021
3	Hypertension (High Blood Pressure) 01/2022 - 11/2020
3	Liver Cirrhosis (Hepatic Cirrhosis) 05/2021 - 07/2016
2	Neoplasms (Cancer) 01/2024 - 12/2023
2	Weight Gain 01/2023 - 07/2022
2	Liver Diseases (Liver Disease) 10/2022 - 05/2021
1	Liver Abscess 01/2024
1	Listeria Meningitis 12/2023
1	Ischemic Stroke 12/2023
1	Pulmonary Embolism 10/2023
1	Pancreatitis 10/2023
1	Disseminated Intravascular Coagulation 10/2023
1	Hyperkalemia 10/2023
1	Schistosomiasis (Bilharziasis) 05/2023
1	Obesity 04/2023
1	Acute Kidney Injury (Acute Renal Failure) 04/2023
1	Myotonic Dystrophy (Dystrophia Myotonica) 01/2023
1	Discitis 10/2022
1	Viremia 07/2022
1	Communicable Diseases (Infectious Diseases) 07/2022
1	Clostridium Infections 01/2022
1	Post-Acute COVID-19 Syndrome 01/2022
1	Osteoporosis 01/2022
1	Vitamin D Deficiency 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Alcoholism (Alcohol Abuse) 01/2022
1	HIV Infections (HIV Infection) 05/2021
1	Mediastinal Emphysema (Pneumomediastinum) 05/2021
1	Ketosis 04/2021
1	Hyperglycemia 04/2021
1	Disease Progression 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021

Drug/Important Bio-Agent (IBA)

7	Antiviral Agents (Antivirals)IBA 10/2023 - 11/2016
3	Carbapenems (Carbapenem Antibiotics)IBA 10/2023 - 01/2020
3	remdesivirIBA 10/2023 - 01/2023
3	dalbavancinIBA 04/2023 - 07/2022
3	Oxygen (Dioxygen)IBA 01/2023 - 01/2020
3	RNA (Ribonucleic Acid)IBA 07/2022 - 01/2022
3	LipidsIBA 07/2022 - 01/2022
2	Vancomycin FDA LinkGeneric 01/2024 - 01/2022
2	mesoglycanIBA 12/2023 - 01/2023
2	Protease Inhibitors (Protease Inhibitor)IBA 10/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 06/2023 - 05/2023
2	CefiderocolIBA 04/2023 - 11/2019
2	Colistin (Coly-Mycin)FDA Link 04/2023 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2022 - 01/2022
2	CreatinineIBA 07/2022 - 12/2021
2	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 07/2016
2	Interleukin-6 (Interleukin 6)IBA 12/2020 - 11/2020
2	Zanamivir (Relenza)FDA Link 12/2019 - 10/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2024
1	Linezolid (Zyvox)FDA Link 01/2024
1	oritavancinIBA 01/2024
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2023
1	N-acetoacetyl-N-deacetylcolchicineIBA 12/2023
1	AnticoagulantsIBA 10/2023
1	Dacarbazine (DIC)FDA LinkGeneric 10/2023
1	Serine Proteases (Serine Protease)IBA 10/2023
1	nafamostatIBA 10/2023
1	LactamsIBA 10/2023
1	Immunoglobulin G (IgG)IBA 06/2023
1	Immunoglobulin M (IgM)IBA 06/2023
1	CytokinesIBA 05/2023
1	nirmatrelvir and ritonavir drug combinationIBA 01/2023
1	molnupiravirIBA 01/2023
1	VaccinesIBA 01/2023
1	RacivirIBA 07/2022
1	imidazole mustard (BIC)IBA 07/2022
1	Triglycerides (Triacylglycerol)IBA 07/2022
1	Vitamin D FDA LinkGeneric 01/2022
1	AntigensIBA 01/2022
1	Proprotein Convertase 9IBA 06/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 05/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2021
1	cobicistat mixture with darunavirIBA 01/2021
1	fibrin fragment D (D-dimer)IBA 01/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Lopinavir FDA Link 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Ritonavir (Norvir)FDA Link 01/2021
1	IronIBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021

Therapy/Procedure

12	Therapeutics 10/2023 - 07/2016
2	Length of Stay 04/2023 - 01/2021
2	Off-Label Use 10/2022 - 03/2020
2	Polypharmacy 01/2022 - 01/2022
2	Extracorporeal Membrane Oxygenation 10/2021 - 10/2019
2	Aftercare (After-Treatment) 05/2021 - 06/2020
2	Artificial Respiration (Mechanical Ventilation) 05/2021 - 10/2019
2	Cannula 05/2021 - 01/2020
2	Long-Term Care 01/2021 - 11/2020
1	Secondary Prevention 01/2022
1	Home Nursing (Nursing, Home) 01/2022
1	Braces 01/2021